# FDA Inspection 809098 - Lanza & Sons, Inc. - November 30, 2012

Source: https://www.keypedia.com/records/fda_inspections/lanza-sons-inc/64d89a3a-1263-42c3-8a8c-1f09d12026a5
Source feed: FDA_Inspections

> FDA Inspection 809098 for Lanza & Sons, Inc. on November 30, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 809098
- Company Name: Lanza & Sons, Inc.
- Inspection Date: 2012-11-30
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 809098 - 2012-11-30](https://www.keypedia.com/records/fda_inspections/lanza-sons-inc/e9482496-b0d7-4029-b3d8-8168934996f2)
- [FDA Inspection 746673 - 2011-09-23](https://www.keypedia.com/records/fda_inspections/lanza-sons-inc/132f369a-ea57-4d02-858f-a75118ad44bb)
- [FDA Inspection 746673 - 2011-09-23](https://www.keypedia.com/records/fda_inspections/lanza-sons-inc/a3fc07bd-ac2b-416c-b8be-585d07ba8ab4)

Company: https://www.keypedia.com/companies/lanza-sons-inc/341c7f00-5f38-48ae-85a4-757f90209eb0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c